Healthios

Liliane Daugny

Archamps

WHERE BIOPHARMA AND MEDTECH COMPANIES

MEET INVESTORS
// Next Edition January 25th-26th 2011// Euro-Swiss Technopole
//Archamps//France

Company Presentations

Introduction

        Field of Activity
       Selected companies representing the following segments of the life science

       industry will be presenting at BioData.

· Genomics/Proteomics
· Bioinformatics
· Drug Development
· Vaccines
· Pre-IPO
· Medtech
· Tool Companies
· Cancer
· Diabetes

         Duration
       Each presentation will last 15 minutes, including Questions and Answers

How to apply?

A fee of CHF 3’300.- (Euros 2'200.-) will be charged in Swiss Francs, after acceptation of your application, for each company presentation.

This includes:

.Two entrances to BioData2010 with access to all sessions
.One invitation to the sponsors and speakers dinner
.Company name and link to company website on www.BioData2010.com
.A 2-page company profile in the participants book that is distributed to all meeting attendees
.Full delegate package
.Coffee break refreshments
.Luncheons

Any additional person wishing to attend the meeting will have to pay the regular participant fee.

If you wish to apply for a company presentation, please complete and send the online company presentation registration form (see below).

You will receive a response within 10 working days. Selected presenting companies will receive a confirmation letter with all technical and billing details.

Please note that the number of available slots is limited and that the application deadline is postponed to Friday, 15th January 2010.

Register online: now closed !

Presenting companies (click here to see the schedule)

                  The 28 presenting companies selected at BioData2010 are:

(see the agenda of the presentations)      

They will have the opportunities to meet investors coming from the following companies:

3i plc, Adcap, Aelios Finance, Akuo Investment, Arca Investment Partners, BioFund, BioMérieux Développement, Bionest Partners, Bordier, CDC, CEA Investissement, Chandra Capital, CIC, CMG Capital, Cowen, Crédit Agricol PE, Cukierman Life Sciences, DEFI Gestion, Deviris Pharma, EIM SA, Endeavour Vision, Entrepreneurs Fund, Europa Partners, Euthemis, Floralis, Hapoalim Securities USA, HBM Partners, Helvea, IMSF International, Inventages Venture Capital, Invest Securities, Kepler, Kurma Biofund, Laverda Ltd, Merieux Developpement, Neomed, NWI investment Fund, Oddo AM, OSEO, PARFinance, Privateq Advisors, Richefield Partners, Sectoral, SME BioAdvisor, Sofinova, UBS, Vespucci Capital, Wealth Management Advisors, Widmann Associates, Healthios...

ow to apply?